1 |
Ali AM, Mir R, Bashir S, et al (2011). Relationship between the levels of serum thyroid hormones and the risk of breast cancer. J Biology Agriculture Healthcare, 1, 56-9.
|
2 |
Altman DG (1998). Sbe24: metan-an alternative meta-analysis command. Stata Tech Bull Reprints, 8, 86-100.
|
3 |
Altman DG (2001). Systematic reviews of evaluations of prognostic variables. BMJ, 323, 224-8.
DOI
ScienceOn
|
4 |
Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
DOI
ScienceOn
|
5 |
Biondi B, Cooper DS (2008). The clinical significance of subclinical thyroid dysfunction. Endocr Rev, 29, 76-131.
DOI
ScienceOn
|
6 |
Cengiz O, Bozkurt B, Unal B, et al (2004). The relationship between prognostic factors of breast cancer and thyroid disorders in Turkish women. J Surg Oncol, 87, 19-25.
DOI
|
7 |
Colditz GA, Burdick E, Mosteller F (1995). Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary. Am J Epidemiol, 142, 371-82.
|
8 |
Dai G, Levy O, Carrasco N (1996). Cloning and characterization of the thyroid iodide transporter. Nature, 379, 458-60.
DOI
ScienceOn
|
9 |
DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
DOI
ScienceOn
|
10 |
Dinda S, Sanchez A, Moudgil V (2002). Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells. Oncogene, 21, 761-8.
DOI
|
11 |
Ditsch N, Liebhardt S, Von Koch F, et al (2010). Thyroid function in breast cancer patients. Anticancer Res, 30, 1713-7.
|
12 |
Egger M, Smith GD, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
DOI
ScienceOn
|
13 |
Farahati J, Roggenbuck D, Gilman E, et al (2012). Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer. Clin Chem Lab Med, 50, 709-14.
|
14 |
Giustarini E, Pinchera A, Fierabracci P, et al (2006). Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol, 154, 645-9.
DOI
ScienceOn
|
15 |
Harris RJ, Bradburn MJ, Deeks JJ, et al (2008). metan: fixed-and random-effects meta-analysis. Stata J, 8, 3-28.
|
16 |
Hellevik AI, Asvold BO, Bjoro T, et al (2009). Thyroid function and cancer risk: a prospective population study. Cancer Epidemiol Biomarkers Prev, 18, 570-4.
DOI
|
17 |
Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.
DOI
ScienceOn
|
18 |
Kogai T, Curcio F, Hyman S, et al (2000). Induction of follicle formation in long-term cultured normal human thyroid cells treated with thyrotropin stimulates iodide uptake but not sodium/iodide symporter messenger RNA and protein expression. J Endocrinol, 167, 125-35.
DOI
ScienceOn
|
19 |
Kuijpens JL, Nyklictek I, Louwman MW, et al (2005). Hypothyroidism might be related to breast cancer in postmenopausal women. Thyroid, 15, 1253-9.
DOI
|
20 |
Mittal A, Poudel B, Pandeya DR, et al (2012). Metabolic changes enhance the cardiovascular risk with differentiated thyroid carcinoma a case control study from Manipal Teaching Hospital of Nepal. Asian Pac J Cancer Prev, 13, 2335-8.
과학기술학회마을
DOI
|
21 |
Nogueira CR, Brentani MM (1996). Triiodothyronine mimics the effects of estrogen in breast cancer cell lines. J Steroid Biochem Mol Biol, 59, 271-9.
DOI
|
22 |
Simon MS, Tang MT, Bernstein L, et al (2002). Do thyroid disorders increase the risk of breast cancer? Cancer Epidemiol Biomarkers Prev, 11, 1574-8.
|
23 |
Prinzi N, Baldini E, Sorrenti S, et al (2014). Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3, 921 patients. Breast Cancer Res Treat, 144, 683-8.
DOI
|
24 |
Saito T, Endo T, Kawaguchi A, et al (1997). Increased expression of the Na+/I- symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue. J Clin Endocrinol Metab, 82, 3331-6.
|
25 |
Saraiva PP, Figueiredo NB, Padovani CR, et al (2005). Profile of thyroid hormones in breast cancer patients. Braz J Med Biol Res, 38, 761-5.
|
26 |
Smyth P, Smith D, Dermott EM, et al (1996). A direct relationship between thyroid enlargement and breast cancer. J Clin Endocrinol Metab, 81, 937-41.
|
27 |
Stroup DF, Berlin JA, Morton SC, et al (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA, 283, 2008-12.
DOI
ScienceOn
|
28 |
Szychta P, Szychta W, Gesing A, et al (2013). TSH receptor antibodies have predictive value for breast cancerretrospective analysis. Thyroid Res, 6, 8.
DOI
ScienceOn
|
29 |
Tazebay UH, Wapnir IL, Levy O, et al (2000). The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med, 6, 871-8.
DOI
ScienceOn
|
30 |
Turken O, NarIn Y, DemIrbas S, et al (2003). Breast cancer in association with thyroid disorders. Breast Cancer Res, 5, 110-3.
DOI
ScienceOn
|
31 |
Weiss HA, Brinton LA, Potischman NA, et al (1999). Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol, 28, 816-23.
DOI
|
32 |
Uyeturk U, Tatli AM, Gucuk S, et al (2013). Risk factors for stage IV breast cancer at the time of presentation in Turkey. Asian Pac J Cancer Prev, 14, 7445-9.
과학기술학회마을
DOI
ScienceOn
|
33 |
Vadiveloo T, Donnan PT, Cochrane L, Leese GP (2011). The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab, 96, 1-8.
|
34 |
Vanderpump MP (2011). The epidemiology of thyroid disease. Br Med Bull, 99, 39-51.
DOI
|